Dorcas Fulton

NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94).

K. Bélanger, L. Seymour, D. Macdonald, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of recurrent brain stem gliomas and other central nervous system tumors with 5-fluorouracil, CCNU, hydroxyurea, and 6-mercaptopurine.

M. Prados, V. Levin, M. Edwards, 1988, Neurosurgery.

Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

L. Recht, M. Gilbert, W. Mason, 2001, British Journal of Cancer.

Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine.

W. Wara, R. Davis, V. Levin, 1988, Journal of neurosurgery.

Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12).

T. Kinsella, T. Wasserman, J. Delrowe, 1993, International journal of radiation oncology, biology, physics.

A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium study.

M. Prados, M. Mehta, K. Fink, 2000, Neuro-oncology.

Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.

B. Murray, W. Roa, A. Murtha, 2006, Clinical and investigative medicine. Medecine clinique et experimentale.